Global X Cannabis ETF

POTX tracks an index of developed market companies related to cannabis, hemp & CBD.

Invesco S&P SmallCap Energy ETF

Global X Superdividend ETF

SoFi Select 500 ETF

Amplify Junior Silver Miners ETF

These low-priced ETFs could lead to huge gains in the coming months based on encouraging market trends.

5 ETFs Under $20 to Buy for Outperformance

Amplify Seymour Cannabis ETF

Amplify Alternative Harvest ETF

Amplify US Alternative Harvest ETF

AdvisorShares Pure US Cannabis ETF

AXS Cannabis ETF

Cambria Cannabis ETF

AdvisorShares Vice ETF

AdvisorShares Pure Cannabis ETF 

Elad Barak founded Voyager Products, a health tech startup creating personalized dosing dispensers for cannabis beverages. Focused on hardware side, proprietary technology.

Dose Your Own Drink (Podcast Transcript)

Careers In Cannabis (Podcast Transcript)

Canopy Growth

Curaleaf Holdings, Inc.

Green Thumb Industries Inc.

MedMen Enterprises Inc.

Trulieve Cannabis Corp.

Tilray Brands

Waiting For The Top Down In Cannabis (Podcast)

Cronos Group

Julian Lin has a new cannabis focused marketplace service, Cannabis Growth Portfolio. We discuss his thoughts on EBITDA, ETFs using total return swaps to own US MSOs, rebalancing away from Canadian operators.

Julian Lin's Highest Conviction Idea (Ever)? Cannabis. (Podcast Transcript)

Brian Sekandi started careerscannabis.com, the first job search engine for the cannabis industry in North America. Simplifying the application process and improving the recruitment experience with digital technology.

Careers In Cannabis (Podcast)

Kelowna, BC, Aug. 24, 2021 (GLOBE NEWSWIRE) -- Avant Brands Inc (TSX: AVNT) (OTCQX: AVTBF) (FRA: 1BUP) (“Avant”), a leading producer of handcrafted, high quality cannabis products, announces that it has been added to the Global X Cannabis ETF (NASDAQ: POTX), which is listed on the NASDAQ exchange. “Our recent efforts to expand our investor base by rebranding with concurrent dual graduations to the Toronto Stock Exchange and OTCQX have resulted in Avant gaining institutional exposure,” said Norton Singhavon, Founder and CEO of Avant Brands. “Our inclusion in the Global X Cannabis ETF will provide us with the opportunity to continue expanding our exposure to investors and institutions across North America and globally.” The Global X Cannabis ETF seeks to invest in companies across the cannabis industry. This includes companies involved in the legal production, growth and distribution of cannabis and industrial hemp, as well as those involved in providing financial services to the cannabis industry, pharmaceutical applications of cannabis, cannabidiol (i.e., CBD), or other related uses including but not limited to extracts, derivatives, or synthetic versions. Global X Cannabis ETF joins the Horizons Marijuana Life Sciences Index ETF (TSX: HMMJ) to include Avant Brands as a portfolio holding in their ETF. About Avant Brands Avant is an innovative, market-leading cannabis brand house. Avant has multiple licensed and operational production facilities across Canada, which produce high-quality, handcrafted cannabis products for our highly desired, and award-winning consumer brands, sold across both recreational and medical channels. Avant's recreational consumer brands includes BLK MKT™, Tenzo™, Cognōscente™ and Treehugger™, all produced from rare and exceptional cultivars, and sold in British Columbia, Ontario, Saskatchewan, Manitoba, New Brunswick, and Yukon. The Company's medical cannabis brand, GreenTec™, is distributed nationwide, directly to qualified patients through its GreenTec Medical portal, and through various medical cannabis partners. Avant is a publicly traded corporation listed on the Toronto Stock Exchange (TSX: AVNT), and cross-trades on the OTCQX Best Market (OTCQX: AVTBF) and Frankfurt Stock Exchange (FRA: 1BUP). The Company is headquartered in Kelowna, British Columbia and has operations in British Columbia, Alberta and Ontario. CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION: This news release includes certain “forward-looking information” as defined under applicable Canadian securities legislation, including statements regarding the plans, intentions, beliefs, and current expectations of the Company with respect to future business activities and operating performance. Forward-looking information is often identified by the words "may", "would", "could", "should", "will", "intend", "plan", "anticipate", "believe", "estimate", "expect" or similar expressions and includes information regarding: the impacts of the Company's inclusion in the Global X Cannabis ETF; and expectations for other economic, business, and/or competitive factors. Forward-looking information is necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking information.   Examples include statements that the Company will operate in a fiscally disciplined manner; build long-term shareholder value; reduce operational expenses; or increase its revenue and gross margins. Investors are cautioned that forward-looking information is not based on historical fact but instead reflects management's expectations, estimates or projections concerning future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although the Company believes that the expectations reflected in such forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance, or achievements of the Company. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information are the following: regulatory and licensing risks; changes in consumer demand and preferences; changes in general economic, business and political conditions, including changes in the financial markets; the global regulatory landscape and enforcement related to cannabis, including political risks and risks relating to regulatory change; compliance with extensive government regulation; public opinion and perception of the cannabis industry; the impact of COVID-19; and the risk factors set out in the Company's annual information form dated March 16, 2021, filed with Canadian securities regulators and available on the Company's profile on SEDAR at www.sedar.com. Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated, or expected. Although the Company has attempted to identify important risks, uncertainties and factors that could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. Accordingly, readers should not place undue reliance on forward-looking information, which speak only as of the date of this news release. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.

Avant Brands Joins NASDAQ-Listed Cannabis ETF

Julian Lin's Highest Conviction Idea (Ever)? Cannabis. (Podcast)

Agrify

Altria

Scotts Miracle-Gro

Alan Brochstein, a friend of the podcast and now a 3peat guest, is the founder of 420 Investor and New Cannabis Ventures. Thoughts on uplisting, the ETF MSOS, volume and valuation issues and confronting the California cannabis landscape.

Alan Brochstein: The Longer Legislation Takes, The Better For Cannabis Companies (Podcast Transcript)

GW Pharmaceuticals

Alan Brochstein: The Longer Legislation Takes, The Better For Cannabis Companies (Podcast)

George Jage discusses building out a nascent cannabis industry with trade shows and business media. SAFE banking coming? The unfortunate influence of outside money. Shifting to the CPG industry. Unlocking valuation.

Unpacking The Cannabis Industry (Podcast Transcript)

Is POTX A Buy? Evaluating The Global Cannabis ETF

George Jage discusses building out a nascent cannabis industry with trade shows and business media.

Unpacking The Cannabis Industry (Podcast)

Unrivaled Cannabis (Podcast)

It's not secret in the capital markets that the cannabis industry is experiencing exponential growth, but if you're still wary of its potential, maybe $30 billion by next year might convince you. “Recent waves of medical and adult-use legalization across the United States suggest the cannabis industry is set to outpace its already impressive numbers [.

An ETF to Play as Cannabis Industry Projected to Surpass $30 Billion in 2022

Gauging Growth In Michigan (Podcast)

Making Cannabis Shine (Podcast Transcript)

Adrian Sedlin is founder and CEO of Canndescent, a vertically integrated cannabis flower brand out of Santa Barbara. California's cannabis landscape suffers from oversupply and not enough legal retail, an unregulated grey market that's 2-3x legal market.

Making Cannabis Shine (Podcast)

Emily Paxhia is co-founder and Managing Partner of Poseidon Asset Management, one of the earliest and longest-running funds in the cannabis space. The disappointing political picture around cannabis decriminalization and legalization.

Current State Of Cannabis (Podcast Transcript)

Innovative Industrial Properties

Stem, Inc

Our first two Master Classes in cannabis investing with SA authors James Baker and Julian Lin were so successful we're coming back for #3! We discuss why retail cannabis investors are focused too much on near term catalysts and missing the long term picture.

Master Class In Cannabis Investing, Part 3 (Podcast Transcript)

Current State Of Cannabis (Podcast)

Master Class In Cannabis Investing, Part 3 (Podcast)

Amplify Lithium & Battery Technology ETF

The low-priced ETFs could be attractive as these will enable them to buy more shares instead of just a handful of higher-priced shares for the same amount.

5 ETFs Under $20 Set to Outperform

Silver Spike Acquisition Corp

Are investors ready for the next leg of cannabis legalization and what it does to cannabis companies. That's a question asked by Mike Regan and Colin Ferrian who run MJResearchCo, which provides rigorous investment analysis of the legal cannabis industry.

Are Investors Ready For Legal Cannabis? (Podcast)

The cannabis industry has become a relatively steady performer in the capital markets with more years under its belt. The sector is proving it's not a thematic smoke-and-mirrors play with strong outperformers like the Global X Cannabis ETF (POTX).

News for Global X Cannabis ETF ETF (POTX)